{
  "url": "https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-14",
  "json_url": "https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-14.json",
  "legislation": "uksi/2020/1488",
  "legislation_title": "The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020",
  "legislation_url": "https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020",
  "path": "schedule/2/paragraph/14",
  "kind": "paragraph",
  "number": "14",
  "heading": null,
  "text": "In regulation 20 (amendment of Schedule 4 (standard provisions of licences under Part 3))—\n(a) for paragraph (2) substitute—\n“(2) For paragraph 13(b) substitute—\n“(b) in the case of a product for sale or supply—\n(i) in Great Britain, a UK marketing authorisation, certificate of registration or traditional herbal registration, or\n(ii) in Northern Ireland, a marketing authorisation, Article 126a authorisation, certificate of registration or traditional herbal registration,\ncontains provisions relating to them,”.”;\n(b) after paragraph (2) insert—\n“(2A) After paragraph 14 insert—\n“14A A licence holder—\n(a) in Great Britain may only supply a special medicinal product to a person in Northern Ireland, and\n(b) in Northern Ireland may only supply a special medicinal product to a person in Great Britain,\nin response to an order which satisfies the requirements of regulation 167.”.”;\n(c) for paragraph (3) substitute—\n“(3) In the heading of Part 2, after “State Other Than an EEA State” insert “ / Country other than an Approved Country for Import ”.”;\n(d) for paragraph (4) substitute—\n“(4) In paragraph 15, for “from a state other than an EEA State” substitute—\n“from—\n(a) in the case of an import into Great Britain, a country other than Northern Ireland or a country other than an approved country for import, or\n(b) in the case of an import into Northern Ireland, a country other than an EEA State”.\n(4A) In paragraphs 22(1) and 23, for “a state other than an EEA State” substitute “ , in the case of an import into Great Britain, a country other than Northern Ireland or a country other than an approved country for import and in the case of an import into Northern Ireland, a country other than an EEA State ”.\n(4B) After paragraph 23, insert—\n“23A A licence holder—\n(a) in Great Britain may only supply a special medicinal product to a person in Northern Ireland, and\n(b) in Northern Ireland may only supply a special medicinal product to a person in Great Britain,\nin response to an order which satisfies the requirements of regulation 167.”.”;\n(e) for paragraph (6) substitute—\n“(6) In paragraph 33, for “another EEA State” substitute “ , in the case of an import into Great Britain, an approved country for import and in the case of an import into Northern Ireland, an EEA State ”.”;\n(f) after paragraph (6) insert—\n“(7) After paragraph 41 insert—\n“41A A licence holder—\n(a) in Great Britain may only supply a special medicinal product to a person in Northern Ireland, and\n(b) in Northern Ireland may only supply a special medicinal product to a person in Great Britain,\nin response to an order which satisfies the requirements of regulation 167.”.”.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Sch. 2 para. 14 in force at 31.12.2020 immediately before IP completion day, see reg. 1"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/14",
    "retrieved_at": "2026-10-28T22:20:46.695666+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}